QHM-2025-8125 Dalston Medical Group- Local Enhanced Service

The procurement process involves the NHS North East and North Cumbria Integrated Care Board awarding a contract titled "QHM-2025-8125 Dalston Medical Group- Local Enhanced Service" in the health services industry category. This contract, focusing on services such as near-patient testing, drug monitoring, and minor injury treatments, is located in the UKC region. The award follows a Direct Award Process as outlined by the Health Care Services (Provider Selection Regime) regulations 2023 and does not adhere to the Procurement Act 2023 or Procurement Regulations 2024.

The contract, executed without prior competition, officially began on 1st April 2025, with services already being delivered on an implied contract. The procurement method is limited, and the service has been awarded to Dalston Medical Group. Though formally signed on 1st October 2025, the contract remains active with a nominal value of £0.01 due to its activity-based nature, covering until 31st March 2026.

This tender opens opportunities for businesses that specialise in healthcare services and have the capability to provide niche offerings such as high-risk drug monitoring and hormonal injection administration. It represents significant growth potential for businesses adept in delivering specialised medical services within the UK healthcare sector. Organisations with a presence or interest in the North East and North Cumbria region will find this tender particularly advantageous.

The procurement process being a direct award highlights the importance of having established credentials and proven expertise in similar healthcare services to be competitive in such opportunities. Businesses with the capability to provide these specialised services can leverage this contract to strengthen their foothold in the healthcare sector.